Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Comparative Effectiveness of Therapies for Children With Autism Spectrum Disorders

Slide: 21 of 36

Key Question 1: Clinical Bottom Line — Benefits Associated With Medical Interventions

Aripiprazole reduces challenging and repetitive behaviors when compared with placebo (strength of evidence: high). Risperidone reduces challenging and repetitive behaviors when compared with placebo (strength of evidence: moderate). Secretin does not improve language, cognition, behavior, communication, autism symptom severity, or socialization (strength of evidence: high).